SCHEMBL3789237

SCHEMBL3789237

Nc1cccc(-c2ccc(Oc3ccccc3)cc2N)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.62
ALDH1A1 P00352 4/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
MAPT P10636 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
MITF O75030 1/20 0.50
GAA P10253 1/20 0.50
GFER P55789 1/20 0.50
NLRP1 Q9C000 1/20 0.50
NOD2 Q9HC29 1/20 0.50
MAOA P21397 3/20 0.48
ATM Q13315 1/20 0.48
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
NLRP3 Q96P20 1/20 0.45
TNK2 Q07912 1/20 0.43
LMNA P02545 1/20 0.43
GPR55 Q9Y2T6 1/20 0.43
NCOA1 Q15788 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25135227 0.92 MAOB (0.65) MAOBALDH1A1MEN1KMT2AMAPT
SCHEMBL3784854 0.88 GSTP1 (0.53) MAOBALDH1A1MEN1KMT2AMAPT
SCHEMBL3790107 0.87 MAOB (0.62) MAOBALDH1A1MEN1KMT2AMAPT
SCHEMBL25135224 0.85 NCOA1 (0.59) MAOBALDH1A1MEN1KMT2AMAPT
SCHEMBL3790624 0.83 MAOA (0.62) MAOBALDH1A1MEN1KMT2AMAPT
SCHEMBL3803204 0.83 MAOB (0.77) MAOBALDH1A1MEN1KMT2AMAPT
SCHEMBL980456 0.81 MAOA (0.69) MAOBALDH1A1MEN1KMT2AMAPT
SCHEMBL4261949 0.81 MAOB (0.81) MAOBALDH1A1MEN1KMT2AMAPT
SCHEMBL29454304 0.81 MAOB (0.81) MAOBALDH1A1MEN1KMT2AMAPT
SCHEMBL3558211 0.81 MAOB (0.62) MAOBALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 MAOB 101/4885ALDH1A1 4339/4885MEN1 174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.